Rationally designed common-light-chain anti-EGFR/c-MET bispecific antibody ALK101 demonstrates potent, broad-spectrum antitumor activity

hLife · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles